Aya Mohr Sasson
Ramat Gan, Please Select, 52621, Israel
NCT Number: NCT03791021
the target of the research is development of a predictive tool for early identification of women which are at higher risk for development of postpartum depression.
the evaluating tools include self portraits and questionnaire during the third trimester of pregnancy.
The suggested research aims to evaluate if and how it would be possible to predict the potential for postpartum mood swing disorders in pregnant women while in the third trimester. The later to prevent the mother from enduring such a detrimental experience, which influences the child development, the family as well as the mother's intimate relationship.
The aim is to identify indicators to predict such potential, using questionnaires and self-portraits during pregnancy, to allow early intervention and treatment. Early diagnosis and quick treatment of pregnant women or post-partum mothers will allow them a higher level of functioning and may even prevent eventually infant neurological and developmental delays and hardships.
Looking for future studies?
Notify Me18 year–40 year
Female
Observational
Ramat Gan, Please Select, 52621, Israel
the target of the research is to evaluate a method based on self portraits and targeted questionnaire done in the third trimester and three months later in order to identify pregnant women in higher risk to develop PPD.
the minimal number of objectives participating in the research would be 100 pregnant women during the third trimester of pregnancy.
the Draw A Person (DAP) test was described by Machover in 1949. it is still considered a reliable and well recognized test for evaluation of mental stress and disorders (Gilory, 2012).
in the research approximately 100 pregnant women in the third trimester would be asked to draw a self portrait in two different time points (during the third trimester and three to six months postpartum). in addition to the self portraits the participants would be asked to fill a set of questionnaires to evaluate the degree of depression, self esteem, personal history of traumatic events, and demographic data.
the self portraits would be evaluated by three judges. the reliability between judges would be tested using KAPPA test.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
the subjects will be given a blank sheet of white paper and a pencil, and will be asked to draw themselves with no other additional instructions.
measure of postpartum depression symptoms.
BDI-II is based on clinical observations of behaviors associated with depression, and it retains the somatic items in accordance with the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria related to loss of energy. ansd sleep disturbances.
The TEQ assesses experiences with nine specific types of traumatic events (e.g., accidents, crime, adult abusive experiences) reported in the empirical literature as having the potential to elicit PTSD symptoms.
Time frame: one year
ratification of a projective tool using self portrait tests to identify patient at risk for developing PPD
Sheba Medical Center
Other Gov
Developing a Postpartum Depression Predicting Tool, During the Third Trimester of Pregnancy
Acronym: ppd
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04364646
Behavior, Behavioral Symptoms
Glen Oaks, New York, United States
View Trial DetailsNCT06285916
Behavior, Behavioral Symptoms
Bentonville, Arkansas, United States
View Trial DetailsNCT05400161
Behavior, Behavioral Symptoms
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT04580901
Behavior, Behavioral Symptoms
Hamilton, Ontario, Canada
View Trial Details